Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.
作者信息
Prondzynski Maksymilian, Lemoine Marc D, Zech Antonia Tl, Horváth András, Di Mauro Vittoria, Koivumäki Jussi T, Kresin Nico, Busch Josefine, Krause Tobias, Krämer Elisabeth, Schlossarek Saskia, Spohn Michael, Friedrich Felix W, Münch Julia, Laufer Sandra D, Redwood Charles, Volk Alexander E, Hansen Arne, Mearini Giulia, Catalucci Daniele, Meyer Christian, Christ Torsten, Patten Monica, Eschenhagen Thomas, Carrier Lucie
出版信息
EMBO Mol Med. 2022 Aug 8;14(8):e16423. doi: 10.15252/emmm.202216423.
Abstract
摘要
相似文献
1
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.α-辅肌动蛋白2突变的疾病建模指导肥厚型心肌病的临床治疗。
EMBO Mol Med. 2022 Aug 8;14(8):e16423. doi: 10.15252/emmm.202216423.
2
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.肌动蛋白 2 突变的疾病建模指导肥厚型心肌病的临床治疗。
EMBO Mol Med. 2019 Dec;11(12):e11115. doi: 10.15252/emmm.201911115. Epub 2019 Nov 3.
3
Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis.扩张型心肌病和心内膜弹力纤维增生症中肌肉LIM蛋白及α-辅肌动蛋白-2基因的突变
Mol Genet Metab. 2003 Sep-Oct;80(1-2):207-15. doi: 10.1016/s1096-7192(03)00142-2.
4
Decreased interactions of mutant muscle LIM protein (MLP) with N-RAP and alpha-actinin and their implication for hypertrophic cardiomyopathy.突变型肌肉LIM蛋白（MLP）与N-RAP和α-辅肌动蛋白的相互作用减少及其与肥厚型心肌病的关系
Cell Tissue Res. 2004 Aug;317(2):129-36. doi: 10.1007/s00441-004-0873-y. Epub 2004 Jun 16.
5
Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study.与家族性肥厚型心肌病和青少年房性心律失常相关的新型α-辅肌动蛋白2变异体：一项大规模平行测序研究
Circ Cardiovasc Genet. 2014 Dec;7(6):741-50. doi: 10.1161/CIRCGENETICS.113.000486. Epub 2014 Aug 30.
6
Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis.α-辅肌动蛋白-2 基因突变导致肥厚型心肌病：全基因组分析。
J Am Coll Cardiol. 2010 Mar 16;55(11):1127-35. doi: 10.1016/j.jacc.2009.11.016.
7
Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation.与ACTA1基因K336E突变相关的致死性肥厚型心肌病和杆状体肌病。
Neuromuscul Disord. 2006 Oct;16(9-10):548-52. doi: 10.1016/j.nmd.2006.07.005. Epub 2006 Sep 1.
8
Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene.肥厚型心肌病中肌联蛋白基因的结构分析：一个新疾病基因的鉴定
Biochem Biophys Res Commun. 1999 Aug 27;262(2):411-7. doi: 10.1006/bbrc.1999.1221.
9
A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy.一种导致肥厚型心肌病的α-原肌球蛋白新发突变。
Circulation. 1995 May 1;91(9):2302-5. doi: 10.1161/01.cir.91.9.2302.
10
Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy.肥厚型心肌病家族中人类肌肉LIM蛋白基因的突变。
Circulation. 2003 Mar 18;107(10):1390-5. doi: 10.1161/01.cir.0000056522.82563.5f.
引用本文的文献
1
How can we use stem cell-derived cardiomyocytes to understand the involvement of energetic metabolism in alterations of cardiac function?我们如何利用干细胞衍生的心肌细胞来了解能量代谢在心脏功能改变中的作用？
Front Mol Med. 2023 Sep 1;3:1222986. doi: 10.3389/fmmed.2023.1222986. eCollection 2023.
2
Transcriptomic Approaches to Cardiomyocyte-Biomaterial Interactions: A Review.转录组学方法在心肌细胞-生物材料相互作用中的研究进展：综述
ACS Biomater Sci Eng. 2024 Jul 8;10(7):4175-4194. doi: 10.1021/acsbiomaterials.4c00303. Epub 2024 Jun 27.
3
Mechanism of Ion Channel Impairment in the Occurrence of Arrhythmia in Patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者心律失常发生中离子通道损伤的机制
Cardiol Rev. 2025;33(3):260-264. doi: 10.1097/CRD.0000000000000612. Epub 2023 Oct 9.
4
Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes.突变导致人诱导多能干细胞衍生心肌细胞中的蛋白病。
Cells. 2022 Sep 2;11(17):2745. doi: 10.3390/cells11172745.
Zotero 插件